Caribou Biosciences

CRBU56

Penny Stock

$2.14arrow_drop_up6.18%$0.12

Penny Stock

CRBU56

$2.14

arrow_drop_up6.18%$0.12

Penny Stock

Performance History

Key Stats
Open	$2.51
Prev. Close	$2.02
EPS	-1.66
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$182.91M
PE Ratio	-

	LOW	HIGH
Day Range	1.98	2.58
52 Week Range	1.50	8.33

Ratios







EPS	-1.66

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Caribou Biosciences (CRBU)

Caribou Biosciences, Inc. (CRBU) is a leading biotechnology company specializing in CRISPR genome editing and gene therapy. The company's stock price history shows a steady growth over the years, reflecting its strong position in the market and promising future prospects. As of the latest quote, CRBU is trading at $50.25 per share, indicating a positive trend in the stock market. This is further supported by the recent news and analysis surrounding Caribou Biosciences, Inc.

In terms of market cap, Caribou Biosciences, Inc. has a solid position, reflecting its value and potential in the industry. The company's smart analysis highlights its strategic approach towards CRISPR technology, which sets it apart from its competitors. Caribou Biosciences, Inc. has consistently shown strong performance compared to the industry, making it an attractive investment option for investors.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Rachel E. Haurwitz Ph.D.
Headquarters: Berkeley
Employees: 137
Exchange: NASDAQ

Keep an eye on Caribou Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Caribou Biosciences's (CRBU) price per share?

The current price per share for Caribou Biosciences (CRBU) is $2.15. The stock has seen a price change of $0.12 recently, indicating a 6.19% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Caribou Biosciences (CRBU)?

For Caribou Biosciences (CRBU), the 52-week high is $8.33, which is 288.34% from the current price. The 52-week low is $1.5, the current price is 43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Caribou Biosciences (CRBU) a growth stock?

Caribou Biosciences (CRBU) has shown an average price growth of -3.4% over the past three years. It has received a score of 4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Caribou Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Caribou Biosciences (CRBU) stock price performance year to date (YTD)?

As of the latest data, Caribou Biosciences (CRBU) has a year-to-date price change of -61.49%. Over the past month, the stock has experienced a price change of 21.19%. Over the last three months, the change has been -2.94%. Over the past six months, the figure is -28.26%.

help

Is Caribou Biosciences (CRBU) a profitable company?

Caribou Biosciences (CRBU) has a net income of -$102.07M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.67K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $34.48M, although specific revenue growth data is currently not available. Operating income is noted at -$116.06M. Furthermore, the EBITDA is -$157.8M.

help

What is the market capitalization of Caribou Biosciences (CRBU)?

Caribou Biosciences (CRBU) has a market capitalization of $182.92M. The average daily trading volume is 2.28, indicating the stock's liquidity and investor engagement.